Screening for hepatocellular carcinoma by Egyptian physicians

Table 4 Relation between physicians’ qualification and knowledge of hepatocellular carcinoma epidemiology

	Highest qualification						P value
	MBBCH		Msc/diploma		MD
	n	%	n	%	n	%
People who should undergo HCC surveillance
Chronic hepatitis B, C and liver cirrhosis	23	92	51	85	59	85	0.666
Positive family history	8	32	10	17	36	52	0.000a
Everyone	4	16	8	13	10	14	0.948
Reduction of deaths from HCC by screening							0.581
< 30%	8	32	14	23	15	22
≥ 30%	17	68	46	77	54	78
Risk factors for progression of the disease
Age	11	44	21	35	31	45	0.49
Regular alcohol consumption	10	40	26	43	35	51	0.562
Gender	4	16	13	22	33	48	0.001a
Obesity, DM	8	32	19	32	28	41	0.525
HCV genotype	10	40	29	48	47	68	0.017a
Co-infection	9	36	28	47	41	59	0.098
Leading cause of HCC							0.053
HCV	19	76	43	72	61	88
HBV	6	24	17	28	8	12
Cause of death of HCC patients							0.427
Cancer	12	48	25	42	30	43
Liver failure	7	28	18	30	28	41
GI or variceal bleeding	6	24	17	28	11	16

^aP < 0.05 considered statistically significant. HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; HCV: Hepatitis C virus.